Berberine alleviates liver fibrosis through inducing ferrous redox to activate ROS-mediated hepatic stellate cells ferroptosis
Abstract Berberine (BBR) has been explored as a potential anti-liver fibrosis agent, but the underlying mechanisms are unknown. In the current study, we aimed to investigate the molecular mechanisms underlying the effect of BBR against liver fibrogenesis in thioacetamide (TAA) and carbon tetrachlori...
Enregistré dans:
Auteurs principaux: | Jiazhi Yi, Shuyun Wu, Siwei Tan, Yunfei Qin, Xing Wang, Jie Jiang, Huiling Liu, Bin Wu |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Nature Publishing Group
2021
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/e20b2c9dbc22437d8bca7f0f63a74de5 |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Emerging Pathological Engagement of Ferroptosis in Gut Diseases
par: Weihua Gao, et autres
Publié: (2021) -
γ-Glutamylcysteine Alleviates Ischemic Stroke-Induced Neuronal Apoptosis by Inhibiting ROS-Mediated Endoplasmic Reticulum Stress
par: Hui-qin Li, et autres
Publié: (2021) -
Exploration of Redox-Related Molecular Patterns and the Redox Score for Prostate Cancer
par: Yue Wu, et autres
Publié: (2021) -
Initiation of hepatic stellate cell activation extends into chronic liver disease
par: Vincent De Smet, et autres
Publié: (2021) -
Targeting Ferroptosis: Pathological Mechanism and Treatment of Ischemia-Reperfusion Injury
par: Xinye Li, et autres
Publié: (2021)